Because JSI-124 has been shown to pharmacologically inhibit STAT3 phosphorylation,[31] we hypothesized that the combination of dasatinib and JSI-124 might cooperate to block glioma cell proliferation and induce apoptosis. This evidence concerns the gene STAT3 and central nervous system cancer.